Skip to main content

Want a detailed portfolio tracker?

Surrozen (SRZN) P/E (2021 - 2026)

Surrozen (SRZN) P/E from Jun 30, 2021 to Jul 21, 2026. The TTM Surrozen (SRZN) P/E is -0.69. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Surrozen (SRZN)

YearP/EChange
2026-0.69-22.29%
2025-0.88+29.68%
2024-0.68+24.67%
2023-0.55+33.93%
2022-0.41-90.39%
2021-4.24N/A

Comparison Surrozen (SRZN) P/E with competitors

Surrozen (SRZN) P/E is -0.69.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.25%
NBYStablecoin Development Corp0.00-100.63%
ENLVEnlivex Ltd0.07-110.92%
FGENFibroGen Inc0.24-135.03%
CHRSCoherus Biosciences Inc0.85-223.84%
FBIOFortress Biotech Inc0.95-238.51%
ORMPOramed Pharmaceuticals Inc1.50-319.37%
AGENAgenus Inc3.01-539.24%
INVAInnoviva Inc3.15-560.32%
VXRTVaxart Inc3.55-618.07%
CRMDCorMedix Inc3.63-629.56%
CVACCureVac N.V.4.45-748.83%
GLPGGalapagos NV4.86-809.14%
ABEOAbeona Therapeutics Inc5.39-886.29%
ABUSArbutus Biopharma Corp5.60-916.66%
ZVRAZevra Therapeutics Inc5.89-959.22%
SPROSpero Therapeutics Inc6.23-1009.02%
CGENCompugen Ltd6.31-1021.50%
RIGLRigel Pharmaceuticals6.87-1102.95%
SLXNSilexion Therapeutics Corp7.30-1164.84%
OMEROmeros Corporation9.26-1451.28%
AUPHAurinia Pharmaceuticals Inc9.58-1498.89%
PLXProtalix BioTherapeutics Inc10.89-1689.50%
ACADAcadia Pharmaceuticals Inc11.73-1811.74%
TBPHTheravance Biopharma Inc12.26-1889.62%
ADMAAdma Biologics Inc12.42-1912.39%
HRMYHarmony Biosciences Holdings Inc13.82-2117.01%
SABSSAB Biotherapeutics Inc14.14-2163.13%
NAGENiagen Bioscience Inc14.82-2262.66%
INCYIncyte Corp15.82-2409.25%
REGNRegeneron Pharmaceuticals Inc15.86-2414.23%
PBYIPuma Biotechnology Inc17.32-2627.17%
CPRXCatalyst Pharmaceuticals Inc17.44-2645.21%
EXELExelixis Inc17.54-2659.62%
TGTXTG Therapeutics Inc18.97-2868.04%
MDXGMimedx Group Inc20.55-3099.57%
XOMAXOMA Royalty Corp22.87-3438.58%
ARGXArgen X SE24.30-3646.31%
CTMXCytomX Therapeutics Inc24.82-3722.66%
XOMAOXOMA Royalty Corp25.34-3799.09%
HALOHalozyme Therapeutics Inc25.62-3839.80%
XOMAPXOMA Royalty Corp25.67-3846.57%
VRTXVertex Pharmaceuticals Inc27.99-4185.85%
RPRXRoyalty Pharma plc - Class A28.69-4286.97%
SLNOSoleno Therapeutics Inc29.02-4334.81%
ASNDAscendis Pharma A/S30.09-4491.01%
LGNDLigand Pharmaceuticals Inc - Class B37.91-5633.29%
APLSApellis Pharmaceuticals Inc39.02-5795.18%
BMRNBiomarin Pharmaceutical Inc42.21-6260.85%
KRYSKrystal Biotech Inc45.34-6717.91%
ONCBeiGene Ltd69.54-10249.48%
PHARPharming Group N.V.75.03-11050.04%
TECHBio-Techne Corp101.96-14980.91%
VCELVericel Corp109.92-16143.11%
ALNYAlnylam Pharmaceuticals Inc117.96-17317.10%
GMABGenmab140.29-20575.55%
TLXTelix Pharmaceuticals Ltd162.15-23766.34%
CORTCorcept Therapeutics Inc212.86-31166.73%